Combination of heterozygous APOB gene mutation with PNPLA3 and TM6SF2 variants promotes steatotic liver disease, cirrhosis and HCC development.
Yasmina ChouikMathilde Di FilippoSylvie RadenneJérôme DumortierPhilippe MoulinMassimo LevreroPublished in: Liver international : official journal of the International Association for the Study of the Liver (2024)